Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes
Research conducted at A. Liebl and co-authors has provided new information about diabetes
November 9th, 2009
"Continuous intraperitoneal insulin infusion (CIPII) with the DiaPort system using regular insulin was compared to continuous subcutaneous insulin infusion (CSII) using insulin Lispro, to investigate the frequency of hypoglycemia, blood glucose control, quality of life, and safety. In this open, randomized, controlled, cross-over, multinational, 12-month study, 60 type 1 diabetic patients with frequent hypoglycemia and/or HbA1c > 7.0% with CSII were randomized to CIPII or CSII," scientists writing in the journal Diabetes Obesity & Metabolism report. "The aim was to obtain the best possible blood glucose while avoiding hypoglycemia. The frequency of...
Source: Obesity & Diabetes Week (2009-11-09)
|
